Study Stopped
Lack of recruitment
Post Market Clinical Follow-up Study Evaluating Performance and Safety of the SenSura® Mio Kids Device
A Multi-Centre Post Market Clinical Follow-up Study Evaluating Performance and Safety of the SenSura® Mio Kids Device in Subjects With a Stoma
1 other identifier
observational
N/A
1 country
1
Brief Summary
This is a post market clinical follow-up study and devices will carry the CE mark once the study is initiated. The investigational device is SenSura® Mio Kids, which is a flat ostomy device. The device is comprised by a baseplate connected to a bag. The coupling between baseplate and bag can be either welded together, referred to as a 1-piece (1P) system, or assembled as separate parts, referred to as a 2-piece (2P) system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 20, 2018
CompletedFirst Posted
Study publicly available on registry
December 24, 2018
CompletedStudy Start
First participant enrolled
April 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 8, 2020
CompletedNovember 17, 2022
November 1, 2022
1.4 years
December 20, 2018
November 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Median wear time
of 8 baseplate changes
2-3 weeks
Eligibility Criteria
The population in this study are subjects from the age of 6 months (calculated from term age meaning 40 gestational weeks) to 4 years either with a colo-, ileo- or urostomy or a loop stoma, or two stomas placed closely together. Subjects can participate in the PMCF study if they fulfill the in-/exclusion criteria as listed in the tables below. However, the per protocol population only include 30 subjects as needed for the compara-tive performance evaluation (Group 1), and these subjects must fulfill inclusion criteria no. 3 (subjects should use a competitor device).
You may qualify if:
- Have a colostomy, ileostomy, urostomy, loop stoma, or two stomas placed closely together
- Have given written informed consent (the legal authorized representative of the subject)
- Group 1 subjects should use a competitor device
You may not qualify if:
- \) Are currently suffering from peristomal skin problems i.e. bleeding and/or broken skin (as-sessed by the investigator)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Coloplast A/Slead
- Children's National Research Institutecollaborator
- Driscoll Children's Hospitalcollaborator
- IWK Health Centrecollaborator
Study Sites (1)
Driscoll Childrens Hospital
Corpus Christi, Texas, 78411, United States
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 20, 2018
First Posted
December 24, 2018
Study Start
April 15, 2019
Primary Completion
September 8, 2020
Study Completion
September 8, 2020
Last Updated
November 17, 2022
Record last verified: 2022-11